Medline Inc. MDLN
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Eric Coldwell |
Robert W. Baird |
33.19 $ |
45 $ |
11.81 % |
03/06/2026 |
| Glen Santangelo |
Barclays |
36.56 $ |
45 $ |
8.44 % |
01/06/2026 |
| Ivan Feinseth |
Tigress Financial |
43.41 $ |
60 $ |
16.59 % |
09/03/2026 |
| Michael Cherny |
Leerink Partners |
48.18 $ |
56 $ |
7.82 % |
25/02/2026 |
| David Larsen |
J.P. Morgan |
43.165 $ |
55 $ |
11.84 % |
21/01/2026 |
| Ed Ridley-Day |
Redburn Partners |
40.52 $ |
42 $ |
1.48 % |
12/01/2026 |
| Elizabeth Anderson |
Evercore ISI |
40.52 $ |
50 $ |
9.48 % |
12/01/2026 |
| Jason Bednar |
Piper Sandler |
40.52 $ |
50 $ |
9.48 % |
12/01/2026 |
| Eric Coldwell |
Robert W. Baird |
40.52 $ |
48 $ |
7.48 % |
12/01/2026 |
| Sean Dodge |
BMO Capital |
40.52 $ |
45 $ |
4.48 % |
12/01/2026 |
| David Roman |
Goldman Sachs |
40.52 $ |
49 $ |
8.48 % |
12/01/2026 |
| Patrick Wood |
Morgan Stanley |
40.52 $ |
48 $ |
7.48 % |
11/01/2026 |